Dino Di Carlo, PhD (he/him/his)

University of California, Los Angeles, California, United States

Dino Di Carlo is the Armond and Elena Hairapetian Professor of Bioengineering at UCLA, serial entrepreneur and inventor. He serves as the Vice Chair of the Bioengineering Department and Deputy Director of a National Science Foundation Engineering Research Center. He is an author on >170 peer-reviewed articles and an inventor on >70 issued patents in the U.S. and across the world. He has received the Presidential Early Career Award for Scientists and Engineers, the highest honor bestowed upon young scientists and engineers. He co-founded several companies in life science research tools, diagnostics, medical device, and pharmaceutical industries and continues to serve on the board of directors. He is a co-founder and director of Cytovale, which has commercialized the FDA-cleared IntelliSep test for sepsis triage in the emergency department. He is Scientific Advisor to Cue Health (NASDAQ:HLTH), which developed the first at-home molecular diagnostic test to be cleared by the FDA.

Disclosure information not submitted.

Presentation(s):

• Accelerating the Discovery of Monoclonal Antibodies (mAbs) and T-cell Receptors (TCRs) using Lab on a Particle Technology

  Tuesday, February 6, 2024
  3:00 PM – 3:30 PM EST